Compare PRSO & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSO | COSM |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4M | 15.8M |
| IPO Year | 2000 | 2009 |
| Metric | PRSO | COSM |
|---|---|---|
| Price | $0.91 | $0.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 624.2K | ★ 7.3M |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.23 | 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | $14,573,000.00 | ★ $65,271,815.00 |
| Revenue This Year | $18.48 | $54.08 |
| Revenue Next Year | $53.57 | $32.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 5.99 | ★ 19.93 |
| 52 Week Low | $0.77 | $0.18 |
| 52 Week High | $2.37 | $1.32 |
| Indicator | PRSO | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 37.00 |
| Support Level | $0.81 | N/A |
| Resistance Level | $0.95 | $0.28 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 9.86 | 32.82 |
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.